In 2021, the WHO revised its classification of central nervous system (CNS) tumors, which has resulted in changes to both diagnostic and treatment landscapes. At NCCN 2023 Annual Conference, this tumor board–style presentation featured 4 case studies demonstrate an evidence-based approach patients with various WHO-defined types diffuse glioma. The Guidelines have been updated reflect reclassifi...

background and objectives: multiple sclerosis (ms) is the most common demyelinating disease of the central nervous system with more than 5.2 million people across the world being afflicted with. magnetic resonance im­aging (mri) is a valuable tool in the diagnosis of ms. this study surveys the results of mri of the central nervous system and paranasal sinuses in the sample of ms patients in ker...